Solicitation SPE2DP-26-D-0001 ATNAA
DEPT OF DEFENSE.DEFENSE LOGISTICS AGENCY.TROOP SUPPORT MEDICAL.DLA TROOP SUPPORT
- Closes
- October 2, 2026
- Published
- September 17, 2026
- Place of performance
- Philadelphia, Pennsylvania 19111
- Notice type
- Market research Started as Sources Sought
- Agency
- DEPT OF DEFENSEDEFENSE LOGISTICS AGENCYDLA TROOP SUPPORT
- Set-aside
- No Set aside used
- PSC
- 6505 — Drugs and Biologicals
- Solicitation no.
- SPE2DP-26-D-0001
Before you bid
- Notice archived
- October 16, 2026 After this the authority stops publishing it.
Scope
Antidote Treatment Nerve Agent Auto-Injector Request For Information (RFI) This RFI does not commit the U.S. Government to issue a solicitation, make an award, or pay any costs associated with responding to this announcement. Item: ANTIDOTE TREATMENT, NERVE AGENT, Automatic, Dual-Chamber, Pralidoxime Chloride Injection, 300 mg per mL, 2 mL, and Atropine Injection, 2.99 mg per mL, 0.7 mL NSN: 6505-
This is an extract. Read the complete notice, documents and any amendments on the issuing authority's site before bidding.
Sourced from the issuing authority's public feed. Offra republishes an extract for discovery; the authority's posting is authoritative.